ECT/Succinylcholine: Biochemical, Serum and Cardiovascular Changes

NCT00750906 · clinicaltrials.gov ↗
TERMINATED
Status
13
Enrollment
OTHER
Sponsor class

Stopped Study on hold since 2009. Awaiting FDA approval of Sugammdex to complete second arm of study.

Conditions

Sponsor

University of California, San Francisco